| [1] |
Rhee CM. The interaction between thyroid and kidney disease: an overview of the evidence[J]. Curr Opin Endocrinol Diabetes Obes, 2016, 23(5): 407-415.
|
| [2] |
Abebe N, Kebede T, Wolde M. Assessment of renal function and electrolytes in patients with thyroid dysfunction in Addis Ababa, Ethiopia: a cross sectional study[J]. Pan Afr Med J, 2016, 24: 338.
|
| [3] |
Tanaka Y, Furusyo N, Kato Y, et al. Correlation between thyroid stimulating hormone and renal function in euthyroid residents of Japan: results from the Kyushu and Okinawa Population Study (KOPS)[J]. J Atheroscler Thromb, 2018, 25(4): 335-343.
|
| [4] |
Iglesias P, Bajo MA, Selgas R, et al. Thyroid dysfunction and kidney disease: an update[J]. Rev Endocr Metab Disord, 2017, 18(1): 131-144.
|
| [5] |
Dousdampanis P, Trigka K, Vagenakis GA, et al. The thyroid and the kidney: a complex interplay in health and disease[J]. Int J Artif Organs, 2014, 37(1): 1-12.
|
| [6] |
Bajaj S, Purwar N, Gupta A, et al. Prevalence of hypothyroidism in nondiabetic chronic kidney disease and effect of thyroxine replacement on estimated glomerular filtration rate[J]. Indian J Nephrol, 2017, 27(2): 104-107.
|
| [7] |
Peixoto de Miranda éJF, Bittencourt MS, Goulart AC, et al. Thyrotropin levels are associated with chronic kidney disease among healthy subjects in cross-sectional analysis of the Brazilian longitudinal study of adult health (ELSA-Brasil)[J]. Clin Exp Nephrol, 2017, 21(6): 1035-1043.
|
| [8] |
Sanai T, Okamura K, Rikitake S, et al. The high prevalence of reversible subclinical hypothyroidism with elevated serum thyroglobulin levels in chronic kidney disease patients[J]. Clin Nephrol, 2017, 87(5): 237-244.
|
| [9] |
Pakfetrat M, Dabbaghmanesh MH, Karimi Z, et al. Prevalence of hypothyroidism and thyroid nodule in chronic hemodialysis Iranian patients[J]. Hemodial Int, 2017, 21(1): 84-89.
|
| [10] |
Srivastava S, Rajput J, Shrivastava M, et al. Correlation of thyroid hormone profile with biochemical markers of renal function in patients with undialyzed chronic kidney disease[J]. Indian J Endocrinol Metab, 2018, 22(3): 316-320.
|
| [11] |
Lo JC, Chertow GM, Go AS, et al. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease[J]. Kidney Int, 2005, 67(3): 1047-1052.
|
| [12] |
Rhee CM, Kalantar-Zadeh K, Streja E, et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease[J]. Nephrol Dial Transplant, 2015, 30(2): 282-287.
|
| [13] |
Rhee CM, Chen Y, You AS, et al. Thyroid status, quality of life, and mental health in patients on hemodialysis[J]. Clin J Am Soc Nephrol, 2017, 12(8): 1274-1283.
|
| [14] |
Lo JC, Beck GJ, Kaysen GA, et al. Thyroid function in end stage renal disease and effects of frequent hemodialysis[J]. Hemodial Int, 2017, 21(4): 534-541.
|
| [15] |
Sanai T, Nagashima A, Okamura K, et al. Thyroid function in patients on continuous ambulatory peritoneal dialysis in comparison with chronic kidney disease[J]. Clin Nephrol, 2018, 89(3): 181-186.
|
| [16] |
Sánchez V, Paniagua R, Prado MD, et al. High prevalence of diastolic dysfunction in incident patients on peritoneal dialysis: association with low thyroid hormones[J]. Nephron, 2017, 135(2): 120-128.
|
| [17] |
Halilcevic A, Hodzic E, Mesic E, et al. Incidence of subclinical hypothyroidism in renal transplant patients[J]. Mater Sociomed, 2015, 27(2): 108-111.
|
| [18] |
Kraut JA, Madias NE. Adverse effects of the metabolic acidosis of chronic kidney disease[J]. Adv Chronic Kidney Dis, 2017, 24(5): 289-297.
|
| [19] |
Afsar B, Yilmaz MI, Siriopol D, et al. Thyroid function and cardiovascular events in chronic kidney disease patients[J]. J Nephrol, 2017, 30(2): 235-242.
|
| [20] |
Bocchetta A, Ambrosiani L, Baggiani G, et al. Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study[J]. Int J Bipolar Disord, 2018, 6(1): 3.
|
| [21] |
Santos GM, Pantoja CJ, Costa E Silva A, et al. Thyroid hormone receptor binding to DNA and T3-dependent transcriptional activation are inhibited by uremic toxins[J]. Nucl Recept, 2005, 3(1): 1.
|
| [22] |
Rhee CM, Kalantar-Zadeh K, Ravel V, et al. Thyroid status and death risk in US veterans with chronic kidney disease[J]. Mayo Clin Proc, 2018, 93(5): 573-585.
|
| [23] |
Xu H, Brusselaers N, Lindholm B, et al. Thyroid function test derangements and mortality in dialysis patients: a systematic review and Meta-analysis[J]. Am J Kidney Dis, 2016, 68(6): 923-932.
|
| [24] |
Fragidis S, Sombolos K, Thodis E, et al. Low T3 syndrome and long-term mortality in chronic hemodialysis patients[J]. World J Nephrol, 2015, 4(3): 415-422.
|
| [25] |
Rhee CM, You AS, Nguyen DV, et al. Thyroid status and mortality in a prospective hemodialysis cohort[J]. J Clin Endocrinol Metab, 2017, 102(5): 1568-1577.
|
| [26] |
Rhee CM, Kim S, Gillen DL, et al. Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients[J]. J Clin Endocrinol Metab, 2015, 100(4): 1386-1395.
|
| [27] |
Drechsler C, Schneider A, Gutjahr-Lengsfeld L, et al. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients[J]. Am J Kidney Dis, 2014, 63(6): 988-996.
|
| [28] |
Fernández-Reyes MJ, Diez JJ, Collado A, et al. Are low concentrations of serum triiodothyronine a good marker for long-term mortality in hemodialysis patients？[J]. Clin Nephrol, 2010, 73(3): 238-240.
|
| [29] |
Enia G, Panuccio V, Cutrupi S, et al. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis[J]. Nephrol Dial Transplant, 2007, 22(2): 538-544.
|
| [30] |
Chang TI, Nam JY, Shin SK, et al. Low triiodothyronine syndrome and long-term cardiovascular outcome in incident peritoneal dialysis patients[J]. Clin J Am Soc Nephrol, 2015, 10(6): 975-982.
|
| [31] |
Jung HY, Cho JH, Jang HM, et al. Free thyroxine level as an independent predictor of infection-related mortality in patients on peritoneal dialysis: a prospective multicenter cohort study[J]. PLoS One, 2014, 9(12): e112760.
|
| [32] |
Rhee CM, Alexander EK, Bhan I, et al. Hypothyroidism and mortality among dialysis patients[J]. Clin J Am Soc Nephrol, 2013, 8(4): 593-601.
|
| [33] |
Pérez SR, Díez JJ, Bajo MA, et al. Thyrotropin and free thyroxine concentrations do not affect cardiovascular disease and mortality in euthyroid peritoneal dialysis patients[J]. Perit Dial Int, 2013, 33(6): 697-700.
|
| [34] |
Schultheiss UT, Daya N, Grams ME, et al. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the atherosclerosis risk in communities study[J]. Nephrol Dial Transplant, 2017, 32(11): 1874-1881.
|
| [35] |
Meuwese CL, Carrero JJ, Cabezas-Rodríguez I, et al. Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis？[J]. J Intern Med, 2013, 274(6): 584-593.
|
| [36] |
Chang XD, Zhang BH, Lihua L, et al. T3 inhibits the calcification of vascular smooth muscle cells and the potential mechanism[J]. Am J Transl Res, 2016, 8(11): 4694-4704.
|
| [37] |
Sun WH, Liu DH, Gong P, et al. Predicting cardiovascular mortality in chronic kidney disease (CKD) patients[J]. Ann Transplant, 2014, 19: 513-518.
|
| [38] |
Gao JJ, Xu YX, Kong DY, et al. Association of triiodothyronine levels with left ventricular function, cardiovascular events, and mortality in hemodialysis patients[J]. Int J Artif Organs, 2017, 40(2): 60-66.
|
| [39] |
Rhee CM, Brent GA, Kovesdy CP, et al. Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients[J]. Nephrol Dial Transplant, 2015, 30(5): 724-737.
|
| [40] |
Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality[J]. JAMA, 2010, 304(12): 1365-1374.
|
| [41] |
Rhee CM, Curhan GC, Alexander EK, et al. Subclinical hypothyroidism and survival: the effects of heart failure and race[J]. J Clin Endocrinol Metab, 2013, 98(6): 2326-2336.
|
| [42] |
Lim VS. Thyroid function in patients with chronic renal failure[J]. Am J Kidney Dis, 2001, 38(4 Suppl 1): S80-S84.
|
| [43] |
Razvi S, Weaver JU, Butler TJ, et al. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality[J]. Arch Intern Med, 2012, 172(10): 811-817.
|
| [44] |
Shin DH, Lee MJ, Lee HS, et al. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism[J]. Thyroid, 2013, 23(6): 654-661.
|
| [45] |
Hataya Y, Igarashi S, Yamashita T, et al. Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients[J]. Clin Exp Nephrol, 2013, 17(4): 525-531.
|
| [46] |
Mohamedali M, Reddy MS, Vyas A, et al. Thyroid disorders and chronic kidney disease[J]. Int J Nephrol, 2014, 2014: 520281.
|